Total Funding
82
88
Total FundingConvertible Note raised
Growth Score
3 pts
Heat Score
21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17414
Talking Medicines gives Pharma and agencies the intelligence to predict and prove HCP messaging impact, closing the $23Bn blind spot.
- Elizabeth Fairley: Founder, COO | CDO
- Scott Crae: Founder
About the Company
Talking Medicines provides Pharma and Med Comms agencies with AI-powered intelligence to measure, predict, and prove the impact of scientific messaging on HCPs. Using proprietary platforms, DrugVoice and the Message Resonance Score™, the company addresses a $23Bn marketing blind spot, connecting messaging to real-world prescribing behaviour. Its
domain-specific data science enables clients to optimise campaigns, de-risk marketing investment, and demonstrate measurable ROI, positioning Talking Medicines as a strategic, high-value solution in the life sciences marketing ecosystem.
